Pharmaceuticals
Company Overview of Inflabloc Pharmaceuticals, Inc.
Key Executives for Inflabloc Pharmaceuticals, Inc.
| Name | Board Relationships | Title | Age |
| Willem F. O. Spiegel M.B.A | No Relationships | Acting Chief Financial Officer | -- |
| Claire A. Daugherty | No Relationships | Director of Clinical Development | -- |
| John R. Gebhard Ph.d. | No Relationships | Director of Research & Development | -- |
| Paul A. Litka M.d. | No Relationships | Acting Medical Director | 63 |
| David L. Vollmer Ph.d. | No Relationships | Director of Analytical Development and Quality Control | -- |
Inflabloc Pharmaceuticals, Inc. Board Members*
| Name | Board Relationships | Primary Company | Age |
| Peter Friedli | 27 Relationships | Osiris Therapeutics, Inc. | 58 |
| Peter D. Meldrum Ph.D. | 67 Relationships | Myriad Genetics Inc. | 65 |
Inflabloc Pharmaceuticals, Inc. Executive Committees*
| Committee Name | Chairperson | Board Relationships | Members | |
| There is no committee data available. | ||||

CEO COMPENSATION IN THIS INDUSTRY
| Industry Range | ||
| Salary | 449.6K | |
| Bonus | 491.3K | |
| Total Short Term Compensation | 624.8K | |
| Total Value of Options | 10.5M |
INDUSTRY EXECUTIVE CHANGES
Post a JobJobs
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
- Orlando, FL | Consult SoftPosted: May 22
Sponsored Financial Commentaries
Sponsored Links
To contact Inflabloc Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








